LONDON: The EU drug regulator said on Monday it can publish “in a few weeks” the decision about whether to approve the use of Covid-19 Pfizer, Paxlovid, after US drug makers submit application search authorization.
The approval sought is for the treatment of Covid-19 which is mild to moderate at the age of 12 years and above, it weighs at least 40 kilograms and is at high risk for their deteriorating disease, the European Medicine Agency said.